Correction to “Development and Validation of a Stability‐Indicating LC Method for the Determination of Empagliflozin‐Related Substances With Sensitivity Profiling and Robustness Assessment Using Analytical Quality by Design Principles”

Documenti analoghi

• Development and Validation of a Stability‐Indicating LC Method for the Determination of Empagliflozin‐Related Substances With Sensitivity Profiling and Robustness Assessment Using Analytical Quality by Design Principles
  di: Siva Prasad Korikana, et al.
  Pubblicazione: (2026)
• Development and Validation of a Stability‐Indicating Liquid Chromatographic Method for Darolutamide and Its Degradation Impurities and Analytical Quality by Design‐Based Robustness Assessment
  di: Vidya Sagara Reddy Evuri, et al.
  Pubblicazione: (2025)
• Development of a Stability‐Indicating RP‐HPLC Method for Metformin, Linagliptin, and Dapagliflozin Using Analytical Quality by Design Principles
  di: Sanjana Devda, et al.
  Pubblicazione: (2025)
• Analytical Quality by Design (AQbD) Principles in Development and Validation of Stability‐Indicating RP‐HPLC Method for Simultaneous Estimation of Diltiazem HCl and Eugenol in Nanoethosomes
  di: Purva Usgaonkar, et al.
  Pubblicazione: (2024)
• Stability‐Indicating HPLC Method Development and Validation for the Quantification of Tofacitinib Citrate and Its Related Substances Using Hydrophilic Liquid Interaction Chromatography
  di: G. Sivaprasadu, et al.
  Pubblicazione: (2024)